Overview

The global oligonucleotide synthesis market is anticipated to value over USD 4 billion by 2026 with a CAGR of over 12% during the forecast period 2019 to 2026.

Oligonucleotide synthesis deals with the compounding of short fragments of nucleic acid with a specific sequence. Genetic research has a wide scope and has multiple categories of the study. Oligonucleotide synthesis one of the integral sectors in genetics. The variety of clinical and diagnostic applications of oligonucleotide synthesis have fostered the market growth and is positively influencing the CAGR.

Currently, advancements in oligonucleotide synthesizers are the key elements in driving the market. The automated synthesizers that are able to synthesize up to hundreds of DNA/oligo sequences simultaneously are currently trending. The reduced time and expenses along with less volume of samples are expected to be the key features responsible for increasing the oligonucleotide synthesis market share globally.

The fluorescence in situ hybridization (FISH) and PCR primers are major applications of oligonucleotide synthesis. FISH is an integral part of the microbiology industry. Detection, visualization and identification of genetic disorders, microbial culture, etc. has been made easy by FISH. This has stimulated the demand and growth of the market.

The growing interest of the pharma industry towards genetic research is a major driver for the oligonucleotide synthesis market. Currently, most of the pharma companies are investing in genetically engineered products because of their variable applications and preference by healthcare experts. Hence, the pharmaceutical industry is anticipated to have a notable growth in the market of oligonucleotide synthesis.

The focus on genetic research and the promotive expenditure has made North America one of the dominating regions in the market. The interest in the genetic sector and a favourable research environment are positive factors for the research growth in North America. Moreover, the Asia Pacific region is anticipated to have a major oligonucleotide synthesis market share as many government and non-government organizations tend to promote and raise funds for the research in the genetics field.

The key market players are Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare Dharmacon Inc., Agilent Technologies and so on. Thermo Fisher Scientific has a range of advanced genetic equipment with several applications like DNA sequencing, PCR, protein biology, etc. which are anticipated to be drivers for the market growth.

FutureWise Key Takeaways:

●    Investment in genetic research

●    Focus on advanced genetic synthesizers

●    Collaborations with genetic research organizations

Global Oligonucleotide Synthesis Market Segmentation:

By Product:

●    Oligonucleotides

●    Equipment/ synthesizers

●    Reagents

●    Services

By Applications:

●    PCR primers

●    PCR assays-panels

●    Sequencing

●    DNA microarrays

●    Fluorescence in situ hybridization

●    Antisense oligonucleotides

●    Other applications

By End Users:

●    Pharmaceutical-biotechnology companies

●    Diagnostic laboratories

●    Academic research institutes

By Region

●    North America

●    Europe

●    Asia Pacific

●    Latin America

●    Middle East & Africa

Competitive Landscape:

●    Tier 1 players- established companies in the market with a major market share

●    Tier 2 players

●    Emerging players which are growing rapidly

●    New Entrants 

Objectives of the Study:

●    To provide with an exhaustive analysis on the oligonucleotide synthesis market by product, by application, by end user and by region

●    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

●    To evaluate and forecast micro-markets and the overall market

●    To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa.

●    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

●    Profiling of companies to evaluate their market shares, strategies, financials and core competencies.

 

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 970 279 4295

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics